This inventor holds 1 USPTO granted patent. Top assignee: Unversität Zürich. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Roman Meledin and His Patent in Antibody Research.
Introduction
Roman Meledin is an inventor associated with Dübendorf, Switzerland. His listed patent concerns an antibody designed to bias interleukin-2 (IL-2) activity toward CD25.
Latest Patents
Meledin is credited with 1 patent: “A CD25-Biased Anti-IL-2 Antibody.” The invention relates to antibody engineering and the modulation of IL-2 signaling.
Career Highlights
Meledin is associated with the University of Zurich. His patent record reflects work in biomedical research and antibody development.
Collaborations
His listed collaborators include Robert Maka and Onur Boyman.
Conclusion
Roman Meledin’s recorded invention focuses on a CD25-biased anti-IL-2 antibody, connecting his work with research at the University of Zurich and collaboration in biomedical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
